-
Mashup Score: 208th Liquid Biopsy for Precision Oncology Summit - 2 month(s) ago
Reimagine Cancer Detection, Diagnosis & Patient Management through Harnessing the Potential of Liquid Biopsies
Source: lbx-summit.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 2 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 91Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 3 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Michael Serzan: About the hottest new ICI BOTENSILIMAB in Kidney Cancer? - OncoDaily - 3 month(s) ago
Michael Serzan: About the hottest new ICI BOTENSILIMAB in Kidney Cancer? / ASCO, ASCO GU 2024, ASCOGU24, botensilimab, cancer, CheckMate-214, immunotherapy,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
Don’t miss what’s happeningPeople on X are the first to know.Log inSign upSettingsPostPashtoon Kasi MD, MS@pashtoonkasiJust out #NEST-1 trial results Are we on the verge of a new drug combo for colon or rectal cancer? Substantial & brisk responses to justdose of BOTBAL immunotherapy. Pattern & kill is unprecedented. @ASCO #GI24 @OncoAlert Abstract 117Poster Board H2GIF2:33 PM · Jan 20,…
Source: x.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 4 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2171Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial - 4 month(s) ago
Nature Medicine – In a phase 1 trial, a lymph node-targeting mutant KRAS peptide vaccine combined with CpG adjuvant is safe, reduces expression of tumor biomarkers and elicits mutant KRAS-specific…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 89
Findings from 2 trials exploring the application of ctDNA in guiding adjuvant chemotherapy in patients with CRC confirm the benefit of its utility (Abstracts 9 and 12).
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Don’t miss what’s happeningPeople on X are the first to know.Log inSign upSettingsPostPashtoon Kasi MD, MS@pashtoonkasiThis is so cool. #GI24 2 of thetrending clinical trials @ASCO and study results are ours! #ctDNA BESPOKE CRC & #NEST-1 using BOT/BAL novel CTLA-4 in patients with colorectal cancers. Can’t wait till Saturday to present these in more detail. @OncoAlert@brunolarvol9:55 PM · Jan…
Source: x.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Utility and Debate of Liquid Biopsy Assays in Surveillance Setting - 4 month(s) ago
Liquid biopsies impact all phases of the cancer journey, including the surveillance setting—a new scenario in which liquid biopsies are being used in the clinic. The dilemma is what to do with the results of liquid biopsy testing in this setting.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
@RenoHemonc @IbrahimSahinMD1 I agree with @IbrahimSahinMD1. 💡On the wings of #GI24 starting, we would be dealing with these questions even more. ❓What was the high risk part on T3N0 warranting chemo since benefit is small. I’d repeat assay(s) before escalating to more imaging. https://t.co/hh7vrPriIP https://t.co/mrRUlF1mZ7
-
🩸#LiquidBiopsies are here to stay. 👇🏾A premier conference worth attending. I’ve tried to attend this every year. So much to learn & great networking. ✔️For everyone involved in the field. February 28 - March 1 2024 San Diego, CA @HansonWade #LBxSummit https://t.co/6Idtp3wrQ2 https://t.co/nfR29vkpKn